Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06552364
PHASE4

Air Pollution and Inhaled Corticosteroids in COPD

Sponsor: University of British Columbia

View on ClinicalTrials.gov

Summary

Studies have shown that people with chronic obstructive pulmonary disease (COPD) have worse symptoms after breathing polluted air. People with COPD also often need to go to the hospital if they get a virus or other bug. One of the main drugs taken for COPD treatment (inhaled corticosteroid) may change COPD patients' lungs in ways that make it harder to deal with bugs, especially if they breathe in polluted air. If so, this could cause more frequent hospital visits. On the other hand, the same drug (inhaled corticosteroid) helps some people control symptoms, and may help them avoid hospital visits. The APEL investigators are conducting this study (APIC) to understand if this drug (inhaled corticosteroid), in combination with polluted air, will change the lungs of those with COPD in ways that make it more likely to catch bugs or have other problems.

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2025-04-01

Completion Date

2028-12-31

Last Updated

2025-03-27

Healthy Volunteers

No

Conditions

Interventions

DRUG

LABA+LAMA

1 dose per day (AM)

DRUG

LABA+LAMA+ICS

1 dose per day (AM)

OTHER

Filtered Air

Exposure to HEPA filtered air, as a control

OTHER

Diesel Exhaust

Diesel exhaust standardized to 300µg/m³ of particulate matter with a diameter of 2.5 micrometers or less (PM2.5).